Clinical Trial Update: Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating novel approaches to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation, with results compared to con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Hodgkin Lymphoma
• Leukemia
• Myelodysplastic Syndromes
• Small Lymphocytic Lymphoma

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Acute Leukemia, Chronic Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23